Daré Bioscience, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $24.7M | $15.7M | $10.5M | $34.7M | $51.7M | $4.7M | $4.8M | $6.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $27.1M | $18.4M | $17.5M | $43.0M | $55.3M | $7.0M | $6.4M | $7.2M |
| Property, Plant & Equipment | $1.6M | $1.3M | $656.0K | $64.9K | $26.0K | $37.9K | $63.5K | $9.4K |
| Goodwill | — | — | — | — | — | — | — | $0 |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $32.5M | $22.1M | $21.3M | $43.8M | $55.8M | $7.6M | $7.4M | $7.8M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $1.5M | $3.4M | $2.0M | $2.1M | $1.0M | $1.1M | $459.7K |
| Total Current Liabilities | $23.7M | $21.6M | $20.5M | $31.6M | $16.1M | $7.7M | $5.6M | $1.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $29.6M | $28.1M | $26.3M | $32.7M | $17.1M | $8.7M | $7.0M | $1.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-188.7M | $-175.3M | $-171.2M | $-141.1M | $-110.1M | $-71.4M | $-44.0M | $-29.0M |
| Total Stockholders' Equity | $2.8M | $-6.0M | $-5.0M | $11.1M | $38.8M | $-1.2M | $440.8K | $6.7M |